Correlation Between Bio Path and GH Research

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Path and GH Research at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and GH Research into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and GH Research PLC, you can compare the effects of market volatilities on Bio Path and GH Research and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of GH Research. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and GH Research.

Diversification Opportunities for Bio Path and GH Research

-0.22
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bio and GHRS is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and GH Research PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GH Research PLC and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with GH Research. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GH Research PLC has no effect on the direction of Bio Path i.e., Bio Path and GH Research go up and down completely randomly.

Pair Corralation between Bio Path and GH Research

Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the GH Research. In addition to that, Bio Path is 5.86 times more volatile than GH Research PLC. It trades about -0.19 of its total potential returns per unit of risk. GH Research PLC is currently generating about -0.71 per unit of volatility. If you would invest  1,799  in GH Research PLC on December 3, 2024 and sell it today you would lose (878.00) from holding GH Research PLC or give up 48.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy71.43%
ValuesDaily Returns

Bio Path Holdings  vs.  GH Research PLC

 Performance 
       Timeline  
Bio Path Holdings 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Bio Path Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
GH Research PLC 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in GH Research PLC are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, GH Research unveiled solid returns over the last few months and may actually be approaching a breakup point.

Bio Path and GH Research Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Path and GH Research

The main advantage of trading using opposite Bio Path and GH Research positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, GH Research can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GH Research will offset losses from the drop in GH Research's long position.
The idea behind Bio Path Holdings and GH Research PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Valuation
Check real value of public entities based on technical and fundamental data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments